The sarcoplasmic reticulum Ca2'-ATPase (SERCA2) plays a critical role in the contractile performance of cardiac and slow-twitch skeletal muscle by restoring cytosolic calcium to low resting levels during the contractile cycle. We have previously shown that SERCA2 expression in the heart is altered by a number of pathophysiological stimuli. In an effort to define molecular mechanisms regulating expression of transport calcium from the cytoplasm into the SR lumen, and it is largely responsible for diastolic relaxation of the heart. It also "loads" the SR and thus in part determines the amount of calcium that is available for release from the SR to activate the myofilaments during contraction. Because of their central role in relaxation and contraction of the heart, SERCA2 expression and SR function have been extensively studied in normal and pathological states. '-4 Studies from our laboratory and others have demonstrated that SERCA2 expression is altered by a variety of pathological stimuli. A decrease in the concentration of SERCA2 mRNA occurs in pressure overload-induced cardiac hypertrophy of the right or left ventricle,23 in hypothyroid states,4-5 and in experimental animal and human heart failure.6-9 An increase in mRNA
Its main function is to transport calcium from the cytoplasm into the SR lumen, and it is largely responsible for diastolic relaxation of the heart. It also "loads" the SR and thus in part determines the amount of calcium that is available for release from the SR to activate the myofilaments during contraction. Because of their central role in relaxation and contraction of the heart, SERCA2 expression and SR function have been extensively studied in normal and pathological states. '-4 Studies from our laboratory and others have demonstrated that SERCA2 expression is altered by a variety of pathological stimuli. A decrease in the concentration of SERCA2 mRNA occurs in pressure overload-induced cardiac hypertrophy of the right or left ventricle,23 in hypothyroid states,4-5 and in experimental animal and human heart failure.6-9 An increase in mRNA and protein occurs during hyperthyroid states.4 These changes in SERCA2 protein expression are likely to be in part responsible for abnormalities in calcium cycling and contraction10-13 seen in these conditions. The developmental expression of the SERCA2 gene in rabbit cardiac and skeletal muscle is complex. Cardiac myocytes transcribe only the SERCA2 gene. The mRNA level increases gradually during heart development from fetal to adult stages.'4' Fetal rabbit skeletal muscle expresses both the cardiac/slow-twitch (SERCA2a) and the neonatal fast-twitch (SERCA1b) isoforms at a ratio of 3:1, respectively. In the neonatal period, the SERCA2a isoform is replaced by the fast SERCAla isoform in fast-twitch fiber types, whereas slow-twitch fiber types continue to express only the SERCA2a isoform. 4 Luciferase activity is presented as background-subtracted maximum raw luminometer units divided by the control CAT activity to normalize for differences in transfection efficiency. The data are presented as the percentage of activity of a given construct relative to the construct with maximum activity, which is assigned a value of 100%. The fold increase in activity of the test construct relative to the promoterless pXP2 plasmid is obtained for each group by dividing the test construct value by the promoterless construct value.
DNA Injections Into Myocardium
Injections of the plasmids into adult female Wistar rat myocardium were performed as previously described. 27 In brief, 175-to 200-g rats were anesthetized with a 4% chloral hydrate intraperitoneal injection (1 mL/100 g), the heart was exteriorized through a left lateral thoracotomy, and 50 ,uL of a normal saline solution (containing 10 ,g of test luciferase plasmid) and 2 gg of control pRSVCAT plasmid with 3% Evans blue were injected through a 27-gauge needle into the left ventricular apex. Adult rats were killed at 5 days, and the hearts were homogenized and assayed for luciferase and CAT activity as previously described.27 (The data are presented as described above for the in vitro experiments.) RNA 
Isolation and Analysis
Total RNA from neonatal cardiocytes, C2C12 and Sol 8 myotubes, and heart muscle was isolated by the guanidine thiocyanate method, and 15 ,ug of each sample was analyzed by Northern blots, as previously described.4 A 1.7-kb cDNA fragment (BamHI-3' end) from SERCA2 cDNA was used; this fragment hybridizes to SERCA2a and SERCA2b at the 4.6-kb position and to SERCAla and SERCAlb at the 4.0-kb position on Northern blot analysis. The blots were stripped (of radioactive signal) by washing at 70°C in 0.1 x standard sodium citrate for 1 hour and probed for a-, 3-, and y-actin to assess the degree of differentiation of the various muscle cells. A 900-bp (Pst I-Pst I) fragment of a-actin cDNA was used as a probe. 28 Blots were quantified by direct counting of beta emissions on a Betagen 603 betascope or autoradiographed.
Results
Analysis of SERCA1 and SERCA2 mRNA Levels in Cardiac and Skeletal Muscle Cells
To determine endogenous SERCAI and SERCA2 gene expression levels, we determined their mRNA levels in cardiac and skeletal muscle cells using Northern blot analysis. The relative expression of SERCA1 and SERCA2 mRNA transcripts in different muscle cell types is shown in Fig 2. The murine fast skeletal muscle cell line C2C12 equally coexpresses SERCA1 and SERCA2 after 72 hours in differentiation medium. The To determine whether the same SERCA2 promoter regions are of functional importance in vivo, the same four SERCA2 promoter-luciferase reporter constructs were injected into the adult rat left ventricular apex. Relative promoter activities, normalized for differences in transfection efficiency, are presented in Fig 4. The region of the gene extending to -284 (from the transcription start site) is necessary to produce high luciferase activity, as observed in the in vitro experiments. Promoter constructs extending to -658 and -1110 (from the transcription start site) produce 73% and 62%, respectively, of the luciferase activity of the most active -284 construct. These in vivo DNA injection results are consistent with the in vitro DNA transfection analyses.
The most active SERCA2 promoter construct produced luciferase values (both in vitro and in vivo) that averaged 5% to 15% of the luciferase value obtained with the potent RSV viral promoter (data not shown).
Transfection efficiencies were similar in all cell types as estimated by the CAT activity emanating from the control pSV2CAT plasmid. Discussion
The present study was designed to identify the 5'
promoter regions critical for the transcriptional activity of the SERCA2 gene in cardiac muscle cells. Using deletion constructs linked to a luciferase reporter plasmid in transient transfection assays, we were able to identify a region of the SERCA2 gene extending from the transcription start site to the -284-bp position as necessary and sufficient to promote transcription of the gene. This is true when the gene is studied in vitro in embryonic cardiocytes, during Sol 8 and C,C12 skeletal muscle myogenesis in vitro, and in adult myocardium in vivo. This region contains several common consensus sequences that are likely of importance. These include a TATAA-like GATAA box at -32 bp, a CCAAT box at -78 bp, and three Spl consensus sites (GGGCGG) at -122 bp, -185 bp, and -200 bp.18 These bind, respectively, the transcription factor II complex, the CTF family of factors, and the zinc finger protein Spl, which have been previously shown to promote transcription of muscle and nonmuscle eukaryotic genes.29 Of note MEF-1, MEF-2, and M-CAT consensus sequences, which promote muscle-specific transcription of a number of genes in cardiac30-32 and skeletal33'34 muscle, are not present between -72 and -284 bp, the region of the SERCA2 gene that is critical for its transcription.
The Furthermore, the promoter activity is similar across species, including chicken, rat, and rabbit (data not shown). This supports the claim that these cis elements, particularly in the -284 to +1 region, are important across species for transcription of the SERCA2 gene. However, we cannot entirely eliminate the possibility that the differences in the upstream regions are in part due to species differences. This will require identification of the specific cis and trans elements that are operative in each species. However, this alternative explanation is unlikely to be the major cause of the differences. First, slow and fast skeletal muscle cell lines, each derived from the mouse, show discordance in the -658-to -284-bp region. Second, cardiocytes from different species (embryonic chick versus neonatal rat) produce similar luciferase activity with all constructs tested.
We also demonstrate that the 284-bp region that is required for transcription of the SERCA2 gene in vitro is also necessary and sufficient for transcription of the gene in adult myocardium in vivo. The initial reports of gene transfer into rat heart in vivo by direct injection of plasmid DNA demonstrated that the technique assesses transcription in adult cardiocytes, and not in nonmuscle cells, that is due to the unique ability of the cardiocytes to take up plasmid DNA.36-38 The method was subsequently used to demonstrate that the a-myosin heavy chain promoter, when injected in vivo, would behave in a tissue-specific and thyroid hormone-responsive manner,38 in concordance with previous in vitro studies.39 Subsequent reports of, for example, the myosin light chain-231 and the troponin C genes40 have confirmed a concordance of promoter activity when studied by in vitro transfection and in vivo injection. We likewise have demonstrated in both embryonic cardiocytes in vitro and adult cardiocytes in vivo that a promoter construct extending to -72 bp is inadequate, whereas a promoter construct extending to -284 bp is necessary and sufficient to promote SERCA2 transcription. This concordance confirms that the -72-to -284-bp region contains cis elements critical for the transcription of the SERCA2 gene in both developing and mature cardiocytes.
In conclusion, we have identified a 284-bp proximal promoter region in the SERCA2 gene that is necessary and sufficient to promote transcription in cardiac cells in vitro and in vivo and in differentiating skeletal muscle cells in vitro. The region from -284 to -658 exerts a negative effect in the fast skeletal muscle cell line C2C12 but a positive effect in cardiocytes in vitro and the slow skeletal muscle (Sol 8) 
